Oxygenta Pharmaceutical Ltd - OXYGENTA PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE102E01018

Trade

Oxygenta Pharmaceutical Ltd Corporate Actions

04 Sep , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Aug , 2023

12:00 AM

Results

View Details

24 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

29 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

26 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

27 Feb , 2023

12:00 AM

EGM

View Details

22 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

08 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

08 Feb , 2023

12:00 AM

Results

View Details

03 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Nov , 2022

12:00 AM

Results

View Details

21 Sep , 2022

12:00 AM

AGM

Announcement date: 21 Sep , 2022

View Details

Oxygenta Pharmaceutical Ltd News and Update

Nirma will launch an open offer to purchase a 75% interest in Glenmark Life Sciences for Rs 5,6...

22 September, 2023 |
8:26 PM

Nirma Ltd. will conduct a required open offer to all public shareholders of GLS in accordance with SEBI regulations.

Adani Group forms JV for redevelopment of Mumbai’s Dharavi slum

IIFL News Service |
22 September, 2023 |
8:26 PM

The government obtains substantial dividends from BHEL and Coal India Ltd

IIFL News Service |
21 September, 2023 |
8:24 PM

Vedanta Ltd Shares Hit 14-Month Low Ahead of Key Board Meeting

IIFL News Service |
21 September, 2023 |
8:24 PM

Oxygenta Pharmaceutical Ltd FINANCIALS

No Data Available To Display Chart

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Oxygenta Pharmaceutical Ltd PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	1,131.00	65.52	2,71,508.75	380.64	1.02	4,383.34	98.98
Divis Laboratories Ltd	3,708.40	67.32	98,393.27	345.00	0.81	1,730.00	478.60
Cipla Ltd	1,184.35	34.97	95,796.29	895.02	0.72	3,857.73	305.19
Dr Reddys Laboratories Ltd	5,535.00	24.52	92,004.31	1,639.40	0.72	5,420.10	1,235.20
Torrent Pharmaceuticals Ltd	1,853.55	59.77	62,653.02	323.00	1.19	2,078.00	190.75

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Oxygenta Pharmaceutical Ltd

Sai Sudhakar Vankineni
Managing Director

D Vidya Sagar
Independent Director

Muralidhar R
Director (Technical)

Sangari Kondal Reddy
Independent Director

Padmaja Surapureddy
Independent Director

Kanuganti Raghavender Rao
Executive Director

Veerendra Babu R
Company Sec. & Compli. Officer

Summary

Summary Info Not Found

Reports by Oxygenta Pharmaceutical Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Oxygenta Pharmaceutical Ltd
Investor PresentationConference Call TranscriptConference Call Audio

Oxygenta Pharmaceutical Ltd - OXYGENTA PHARMA Share Price

Oxygenta Pharmaceutical Ltd KEY RATIOS

Oxygenta Pharmaceutical Ltd Corporate Actions

Oxygenta Pharmaceutical Ltd News and Update

Nirma will launch an open offer to purchase a 75% interest in Glenmark Life Sciences for Rs 5,6...

Knowledge Center

Oxygenta Pharmaceutical Ltd SHAREHOLDING SNAPSHOT
25 September , 2023 | 06:02 AM

Oxygenta Pharmaceutical Ltd FINANCIALS

Select Period:

Oxygenta Pharmaceutical Ltd QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

QuickLinks for Oxygenta Pharmaceutical Ltd.

Oxygenta Pharma Information

Oxygenta Pharma Financials

Oxygenta Pharma Results

Oxygenta Pharma News

Oxygenta Pharmaceutical Ltd PEER COMPARISON

MORE ABOUT Oxygenta Pharmaceutical Ltd

Summary

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

Oxygenta Pharmaceutical Ltd - OXYGENTA PHARMA Share Price

Oxygenta Pharmaceutical Ltd KEY RATIOS

Oxygenta Pharmaceutical Ltd Corporate Actions

Oxygenta Pharmaceutical Ltd News and Update

Nirma will launch an open offer to purchase a 75% interest in Glenmark Life Sciences for Rs 5,6...

Knowledge Center

Oxygenta Pharmaceutical Ltd SHAREHOLDING SNAPSHOT 25 September , 2023 | 06:02 AM

Oxygenta Pharmaceutical Ltd FINANCIALS

Select Period:

Oxygenta Pharmaceutical Ltd QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

QuickLinks for Oxygenta Pharmaceutical Ltd.

Oxygenta Pharma Information

Oxygenta Pharma Financials

Oxygenta Pharma Results

Oxygenta Pharma News

Oxygenta Pharmaceutical Ltd PEER COMPARISON

MORE ABOUT Oxygenta Pharmaceutical Ltd

Summary

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

Oxygenta Pharmaceutical Ltd SHAREHOLDING SNAPSHOT
25 September , 2023 | 06:02 AM